After layoffs, Casma eyes path to clinic with autophagy-boosting drug
Casma Therapeutics is unveiling its first preclinical data suggesting that a novel drug can enhance the ability of brain cells to clear out molecular garbage, an approach that it hopes will lead to new treatments ...
Casma Therapeutics is unveiling its first preclinical data suggesting that a novel drug can enhance the ability of brain cells to clear out molecular garbage, an approach that it hopes will lead to new treatments ...
